Drugs / cord blood-RBC concentrates
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05100212 | Dec 2021 → Jan 2025 | retinopathy of prematurity | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | cord blood-RBC concentrates | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05100212 ↗ |
| Known as | CB-RBCs | “transfusing HbF-enriched cord blood-red blood cells (CB-RBCs) instead of adult donor-RBC units (A-RBCs) reduces the incidence of severe ROP” PMID 39113069 ↗ Aug 2024 |